GLP-1 receptor agonists are a class of clinically proven medications that work with your bodys own hormonal signaling to regulate appetite, support metabolic function, and help your body manage weight more effectively
Clinicians typically start patients at the middle ODT dose (5 mg) when switching from low-dose injectables (0.25 to 0.5 mg weekly) and titrate based on response
The deal is part of Trumps most favored nation push, an effort by the president to lower prescription drug prices and bring them more in line with other developed nations
Important eligibility note: GLP-1 medications are prescription treatments for obesity and overweight with related health conditions - not cosmetic weight loss tools
These studies have compared it to both placebo and traditional testosterone gels, yielding promising results in its ability to raise testosterone levels
Then, in 2022, a higher 2 mg dose gained approval, with clinical trials showing up to 73 percent of type 2 diabetic users achieving the recommended blood sugar levels of less than 7 percent, as recommended by the American Diabetes Association
